Historical Control Study on Yiqi Huoxue Decoction(益气活血方) Combined with Dual Anti-Platelet Western Medicine in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
|更新时间:2021-11-17
|
Historical Control Study on Yiqi Huoxue Decoction(益气活血方) Combined with Dual Anti-Platelet Western Medicine in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Journal of Traditional Chinese MedicineVol. 57, Issue 24, Pages: 2108-2112(2016)
KOU Na, XUE Mei, QU Hua, et al. Historical Control Study on Yiqi Huoxue Decoction(益气活血方) Combined with Dual Anti-Platelet Western Medicine in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2016, 57(24): 2108-2112.
KOU Na, XUE Mei, QU Hua, et al. Historical Control Study on Yiqi Huoxue Decoction(益气活血方) Combined with Dual Anti-Platelet Western Medicine in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2016, 57(24): 2108-2112.DOI: 10.13288/j.11-2166/r.2016.24.010.
Historical Control Study on Yiqi Huoxue Decoction(益气活血方) Combined with Dual Anti-Platelet Western Medicine in Treating Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome
Objective To observe clinical curative effect of Yiqi Huoxue Decoction combined with dual antiplatelet western medicine in treating coronary heart disease with Qi deficiency and blood stasis syndrome. Methods Historical control was conducted as study design. The treatment group included 50 outpatients with coronary heart disease with Qi deficiency and blood stasis syndrome treated from November 2013 to December 2015. The control group consisted of 50 outpatients with coronary heart disease with Qi deficiency and blood stasis syndrome accepting dual anti-platelet western medicine conventional therapy( Aspirin Enteric-coated Tablets 100 mg per day orally + Clopidogrel Hydrogen Sulphate Tablets 75 mg per day orally) from December 2010 to January 2012. The treatment group used Chinese medicine of tonifying Qi and activating blood additionally on the basis of conventional therapy of dual anti-platelet western medicine
one dose per day. Maximum platelet aggregation rate
angina scores
Qi deficiency and blood stasis syndrome scores and blood stasis syndrome scores of patients in the two groups before treatment and four weeks and three months after treatment
and number of gastrointestinal adverse reaction cases and score variation before treatment
in the follow-up visit 3 months and 6 months after treatment were observed. Results Compared with that before treatment
maximum platelet aggregation rate
angina scores
Qi deficiency and blood stasis syndrome scores and blood stasis syndrome scores of patients in the treatment group decreased four weeks and three months after treatment( P < 0. 05 or P < 0. 01); compared with four weeks after treatment
angina scores
Qi deficiency and blood stasis syndrome scores and blood stasis syndrome scores of patients in the treatment group decreased more remarkably three months after treatment( P < 0. 05); in the 6 months follow-up visit after treatment
gastrointestinal adverse reaction integral in the treatment group increased( P < 0. 01). Compared with the control group at the same time point
maximum platelet aggregation rate
angina scores
Qi deficiency and blood stasis syndrome scores and blood stasis syndrome scores of patients decreased four weeks and three months after treatment( P < 0. 05 or P < 0. 01)
and gastrointestinal adverse reaction integral decreased in the 3 and 6 months follow-up visit after treatment in the treatment group( P < 0. 05). Conclusion Yiqi Huoxue Decoction combined with dual anti-platelet western medicine could further decrease platelet aggregation rate
improve clinical symptom and decrease gastrointestinal adverse reactions induced by dual anti-platelet western medicine.
Effects of Guanxin Danshen Dripping Pills(冠心丹参滴丸) on the Platelet Activation in the Elderly Patients with Unstable Angina Pectoris of Qi Deficiency and Blood Stasis Syndrome:A Double-blind,Placebo Controlled Study
Analysis of Clinical and Phenomics Characteristics of Patients with Phlegm-Stasis Binding Syndrome and Its Accompanied Patterns in Stable Angina Pectoris of Coronary Heart Disease
Pathogenesis Evolution and Staged Differentiation and Treatment Strategy of Atherosclerotic Plaques:from the Perspective of "Constraint-Putrefaction-Ulceration"
Effects of Yangxin Tongmai Formula (养心通脉方) on Methylation Key Genes and the PERK/ATF4/CHOP Signaling Pathway in Myocardial Tissue of Coronary Heart Disease Model Rats with Blood Stasis Syndrome
Construction of a Diagnostic Model for Coronary Heart Disease with Blood Stasis Syndrome Based on Objective Multi-Modal Data Fusion
Related Author
LIU Wenwu
XUE Xianjun
LUO Xianyuan
JI Weimin
WANG Xuebin
GE Yishan
LI Ying
YIN Wei
Related Institution
The Affiliated Suzhou Science & Technology Town Hospital of Nanjing Medical University
The Central Hospital of Ma′anshan
Liaoning University of Traditional Chinese Medicine
Shenyang Health Service Center
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine